Engineered nanoparticles for biomolecular imaging.

In recent years, the production of nanoparticles (NPs) and exploration of their unusual properties have attracted the attention of physicists, chemists, biologists and engineers. Interest in NPs arises from the fact that the mechanical, chemical, electrical, optical, magnetic, electro-optical and magneto-optical properties of these particles are different from their bulk properties and depend on the particle size. There are numerous areas where nanoparticulate systems are of scientific and technological interest, particularly in biomedicine where the emergence of NPs with specific properties (e.g. magnetic and fluorescence) for contrast agents can lead to advancing the understanding of biological processes at the biomolecular level. This review will cover a full description of the physics of various imaging methods, including MRI, optical techniques, X-rays and CT. In addition, the effect of NPs on the improvement of the mentioned non-invasive imaging methods will be discussed together with their advantages and disadvantages. A detailed discussion will also be provided on the recent advances in imaging agents, such as fluorescent dye-doped silica NPs, quantum dots, gold- and engineered polymeric-NPs, superparamagnetic iron oxide NPs (SPIONs), and multimodal NPs (i.e. nanomaterials that are active in both MRI and optical methods), which are employed to overcome many of the limitations of conventional contrast agents (e.g. gadolinium).

[1]  P. Low,et al.  Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. , 2000, Bioconjugate chemistry.

[2]  Weibo Cai,et al.  Imaging of integrins as biomarkers for tumor angiogenesis. , 2008, Current pharmaceutical design.

[3]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[4]  A. Sherif Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. , 2010, European urology.

[5]  Kai Chen,et al.  Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  R. Weissleder,et al.  Early identification of aortic valve sclerosis using iron oxide enhanced MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[7]  H. Hartung,et al.  Iron Oxide Particle-Enhanced MRI Suggests Variability of Brain Inflammation at Early Stages After Ischemic Stroke , 2007, Stroke.

[8]  Hao Zeng,et al.  Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.

[9]  Kai Chen,et al.  PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.

[10]  Ralph Weissleder,et al.  Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle , 2005, Magnetic resonance in medicine.

[11]  Bernd J Pichler,et al.  Multimodal imaging approaches: PET/CT and PET/MRI. , 2008, Handbook of experimental pharmacology.

[12]  Armin Kolb,et al.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? , 2008, Seminars in nuclear medicine.

[13]  Munshi,et al.  Size Modulation of Polymeric Nanoparticles under Controlled Dynamics of Microemulsion Droplets , 1997, Journal of colloid and interface science.

[14]  Holger Gerhardt,et al.  Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration , 2008, Nature.

[15]  E. Terreno,et al.  In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Morteza Mahmoudi,et al.  An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure , 2009, Nanotechnology.

[17]  Ralph Weissleder,et al.  Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. , 2003, Journal of the American Chemical Society.

[18]  Stephan G Nekolla,et al.  Cardiovascular molecular imaging: an overview. , 2009, Cardiovascular research.

[19]  D. Piwnica-Worms,et al.  Molecular imaging in vivo with PET and SPECT. , 2001, Academic radiology.

[20]  E. Purcell,et al.  Resonance Absorption by Nuclear Magnetic Moments in a Solid , 1946 .

[21]  Asako Narita,et al.  Facile control of silica shell layer thickness on hydrophilic iron oxide nanoparticles via reverse micelle method , 2009 .

[22]  Jin-Sil Choi,et al.  In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.

[23]  K. Nicolay,et al.  Current applications of nanotechnology for magnetic resonance imaging of apoptosis. , 2010, Methods in molecular biology.

[24]  S. Gambhir Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[25]  P. Barber,et al.  Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle. , 2009, Contrast media & molecular imaging.

[26]  Zhiqiang Gao,et al.  Nanoparticles in biomolecular detection , 2006 .

[27]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Ji-Hee Kim,et al.  Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. , 2010, Biomaterials.

[29]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[30]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[31]  J. Frank,et al.  Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats. , 2005, Radiology.

[32]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[33]  P Jackson,et al.  A unique charge‐coupled device/xenon arc lamp based imaging system for the accurate detection and quantitation of multicolour fluorescence , 2001, Electrophoresis.

[34]  Christoph Alexiou,et al.  Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting , 2001 .

[35]  Ajay Kumar Gupta,et al.  Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. , 2007, Nanomedicine.

[36]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[37]  Qing Peng,et al.  A general strategy for nanocrystal synthesis , 2005, Nature.

[38]  J. Franconi,et al.  Nanoparticle phagocytosis and cellular stress: involvement in cellular imaging and in gene therapy against glioma , 2010, NMR in biomedicine.

[39]  S. James Remington,et al.  Negotiating the speed bumps to fluorescence , 2002, Nature Biotechnology.

[40]  Nobuko Uchida,et al.  Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI , 2007, Proceedings of the National Academy of Sciences.

[41]  S. Bossmann,et al.  Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. , 2010, ACS nano.

[42]  P. Joy,et al.  Synthesis of Bio-Compatible SPION–based Aqueous Ferrofluids and Evaluation of RadioFrequency Power Loss for Magnetic Hyperthermia , 2010, Nanoscale research letters.

[43]  Michael A McDonald,et al.  Small Particulate Gadolinium Oxide and Gadolinium Oxide Albumin Microspheres as Multimodal Contrast and Therapeutic Agents , 2003, Investigative radiology.

[44]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[45]  M E Easterly,et al.  A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. , 2001, Lab animal.

[46]  P Stroeve,et al.  Cell toxicity of superparamagnetic iron oxide nanoparticles. , 2009, Journal of colloid and interface science.

[47]  A. Bée,et al.  Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid , 1997, Journal of colloid and interface science.

[48]  Klaas Nicolay,et al.  MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  Klaas Nicolay,et al.  Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. , 2006, Nano letters.

[50]  Benjamin Thierry,et al.  Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells , 2009, Advanced materials.

[51]  Jürgen Kosel,et al.  Recent progress in biomedical applications of magnetic nanoparticles. , 2010, Recent patents on nanotechnology.

[52]  Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Weissleder,et al.  Methotrexate-Induced Accumulation of Fluorescent Annexin V in Collagen-Induced Arthritis , 2005, Molecular imaging.

[54]  Martin W. Brechbiel,et al.  Macromolecular and dendrimer-based magnetic resonance contrast agents , 2010, Acta radiologica.

[55]  R. Weissleder Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[56]  Zahi A Fayad,et al.  Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.

[57]  Dong Wook Kim,et al.  Prostate Cancer-Targeted Imaging Using Magnetofluorescent Polymeric Nanoparticles Functionalized with Bombesin , 2010, Pharmaceutical Research.

[58]  J. Reubi,et al.  Peptide-Based Probes for Cancer Imaging , 2008, Journal of Nuclear Medicine.

[59]  Tsuneji Nagai,et al.  Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. , 2008, International journal of pharmaceutics.

[60]  E. Kresnik,et al.  18F-FDG-PET in the follow-up of thyroid cancer. , 2003, Acta medica Austriaca.

[61]  Wolfhard Semmler,et al.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. , 2007, Cancer research.

[62]  Yi Lu,et al.  Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. , 2010, Advanced drug delivery reviews.

[63]  A. Alavi,et al.  18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[64]  E Terreno,et al.  Advances in metal-based probes for MR molecular imaging applications. , 2010, Current medicinal chemistry.

[65]  R. Weissleder,et al.  Charge-coupled-device based scanner for tomography of fluorescent near-infrared probes in turbid media. , 2002, Medical physics.

[66]  Simon R. Cherry,et al.  Towards in vivo nuclear microscopy: iodine-125 imaging in mice using micro-pinholes , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  Feng Gao,et al.  In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. , 2010, ACS nano.

[68]  T. Webster,et al.  Nanotechnology and nanomaterials: Promises for improved tissue regeneration , 2009 .

[69]  C. Marx,et al.  SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: Results of an intraindividual comparison , 1997, Journal of magnetic resonance imaging : JMRI.

[70]  Philippe Robert,et al.  Comparison of Different Types of Blood Pool Agents (P792, MS325, USPIO) in a Rabbit MR Angiography-like Protocol , 2003, Investigative radiology.

[71]  Ralph Weissleder,et al.  Peroxidase Substrate Nanosensors for MR Imaging , 2004 .

[72]  T J Brady,et al.  Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. , 1992, Radiology.

[73]  T. Kost,et al.  Baculovirus expression vectors for insect and mammalian cells. , 2007, Current drug targets.

[74]  M. Mahmoudi,et al.  Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. , 2011, Nanoscale.

[75]  S R Cherry,et al.  Detector development for microPET II: a 1 microl resolution PET scanner for small animal imaging. , 2001, Physics in medicine and biology.

[76]  K. Nicolay,et al.  A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. , 2004, Bioconjugate chemistry.

[77]  S. Liu,et al.  Synthesis and characterization of two (111)In-labeled DTPA-peptide conjugates. , 2001, Bioconjugate chemistry.

[78]  B. Hamm,et al.  Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. , 2008, Small.

[79]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[80]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[81]  Varpu Marjomäki,et al.  Enhanced gene delivery by avidin-displaying baculovirus. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[82]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[83]  Morteza Mahmoudi,et al.  A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. , 2010, Colloids and surfaces. B, Biointerfaces.

[84]  Taeghwan Hyeon,et al.  Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.

[85]  B. Hamm,et al.  Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging , 2004, Investigative radiology.

[86]  D W Townsend,et al.  A combined PET/CT scanner: the choices. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[87]  J. Minna,et al.  A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer Imaging. , 2009, Journal of materials chemistry.

[88]  H. Vali,et al.  Cytotoxicity and Cell Cycle Effects of Bare and Poly(vinyl alcohol)‐Coated Iron Oxide Nanoparticles in Mouse Fibroblasts , 2009 .

[89]  O. Schmid,et al.  Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. , 2010, Toxicology and applied pharmacology.

[90]  Zhidong Zhang,et al.  Nanocrystalline α-Fe and ε-Fe3N particles prepared by chemical vapor condensation process , 2004 .

[91]  Sungho Jin,et al.  Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.

[92]  R. Andres,et al.  Superparamagnetically labelled neutrophils as potential abscess-specific contrast agent for MRI. , 1995, Magnetic resonance imaging.

[93]  Ralph Weissleder,et al.  Magneto/optical annexin V, a multimodal protein. , 2004, Bioconjugate chemistry.

[94]  Hyuing Zhang,et al.  Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[95]  Biao Yan,et al.  Preparation and magnetic properties of magnetite nanoparticles by sol-gel method , 2010, 2010 3rd International Nanoelectronics Conference (INEC).

[96]  T. Ternynck,et al.  Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[97]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[98]  R Weissleder,et al.  MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. , 1996, AJNR. American journal of neuroradiology.

[99]  A. Bjørnerud,et al.  Renal T  *2 perfusion using an iron oxide nanoparticle contrast agent—influence of T1 relaxation on the first‐pass response , 2002, Magnetic resonance in medicine.

[100]  J. Schlomka,et al.  Experimental feasibility of multi-energy photon-counting K-edge imaging in pre-clinical computed tomography , 2008, Physics in medicine and biology.

[101]  Ralph Weissleder,et al.  Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. , 2002, Bioconjugate chemistry.

[102]  R Weissleder,et al.  First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. , 1990, Radiology.

[103]  Jinming Gao,et al.  MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. , 2009, Biomaterials.

[104]  D. Price,et al.  Role of the β‐amyloid protein in Alzheimer's disease , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[105]  Qiao Sun,et al.  Preparation of water-soluble magnetite nanocrystals from hydrated ferric salts in 2-pyrrolidone: mechanism leading to Fe3O4. , 2004, Angewandte Chemie.

[106]  M. Mahmoudi,et al.  Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked Polyethylene Glycol Fumarate Coating for Application in Imaging and Drug Delivery , 2009 .

[107]  W. Chu,et al.  In vivo Characterization of Gd(BME‐DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function , 1997, NMR in biomedicine.

[108]  W. Cai,et al.  In situ decoration of carbon nanotubes with nearly monodisperse magnetite nanoparticles in liquid polyols , 2007 .

[109]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[110]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[111]  Anna Moore,et al.  In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe , 2004, Cancer Research.

[112]  Zhanwen Xing,et al.  The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging , 2010, Nanotechnology.

[113]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[114]  C. Santos-Cuevas,et al.  Peptides for in vivo target-specific cancer imaging. , 2010, Mini reviews in medicinal chemistry.

[115]  Hui Mao,et al.  Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. , 2008, Small.

[116]  Mingyuan Gao,et al.  One‐Pot Reaction to Synthesize Biocompatible Magnetite Nanoparticles , 2005 .

[117]  Shouhu Xuan,et al.  Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. , 2009, Chemistry.

[118]  Enzo Terreno,et al.  Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.

[119]  Chenjie Xu,et al.  Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. , 2008, Journal of the American Chemical Society.

[120]  Sang Cheon Lee,et al.  Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection. , 2008, Biomaterials.

[121]  B. Chu,et al.  Preparation and Properties of Magnetite and Polymer Magnetite Nanoparticles , 1999 .

[122]  E Stride,et al.  Microbubble ultrasound contrast agents: A review , 2003, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[123]  Jonathan R. Lindner,et al.  Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins , 2003, Circulation.

[124]  Xinmai Yang,et al.  Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent. , 2007, Nano letters.

[125]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[126]  Jinkyu Lee,et al.  Multifunctional nanoparticles possessing a "magnetic motor effect" for drug or gene delivery. , 2005, Angewandte Chemie.

[127]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[128]  B. Choi,et al.  Accuracy of detecting hepatocellular carcinomas before liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[129]  Warren S Warren,et al.  Molecular MRI for sensitive and specific detection of lung metastases , 2010, Proceedings of the National Academy of Sciences.

[130]  J. G. Miller,et al.  In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. , 1998, The Journal of the Acoustical Society of America.

[131]  C. Bartolozzi,et al.  Abdominal MR: liver and pancreas , 1999, European Radiology.

[132]  Hu Yang,et al.  Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis , 2010, Pharmaceutical Research.

[133]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .

[134]  Sophie Laurent,et al.  Classification and basic properties of contrast agents for magnetic resonance imaging. , 2009, Contrast media & molecular imaging.

[135]  A. Bée,et al.  Adsorption of gluconic and citric acids on maghemite particles in aqueous medium , 1996 .

[136]  R. Leahy,et al.  Whole-body skeletal imaging in mice utilizing microPET: optimization of reproducibility and applications in animal models of bone disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[137]  P. Price,et al.  PET as a potential tool for imaging molecular mechanisms of oncology in man. , 2001, Trends in molecular medicine.

[138]  R. Weissleder Molecular imaging: exploring the next frontier. , 1999, Radiology.

[139]  Abbas S. Milani,et al.  Multiphysics Flow Modeling and in Vitro Toxicity of Iron Oxide Nanoparticles Coated with Poly(vinyl alcohol) , 2009 .

[140]  Ralph Weissleder,et al.  Novel near-infrared cyanine fluorochromes: synthesis, properties, and bioconjugation. , 2002, Bioconjugate chemistry.

[141]  R. Thompson,et al.  Mechanisms of angiogenesis. , 1987, Annual review of physiology.

[142]  H. Gerth,et al.  Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors , 2007, Journal of Nuclear Medicine.

[143]  Duxin Sun,et al.  Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.

[144]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[145]  Si-Shen Feng,et al.  Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. , 2007, Biomaterials.

[146]  P. Opolon,et al.  In Vitro Echogenicity Characterization of Poly[lactide-coglycolide] (PLGA) Microparticles and Preliminary In Vivo Ultrasound Enhancement Study for Ultrasound Contrast Agent Application , 2005, Investigative radiology.

[147]  Hiroyuki Honda,et al.  Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of “heat-controlled necrosis” with heat shock protein expression , 2006, Cancer Immunology, Immunotherapy.

[148]  G. Dai,et al.  Novel membrane‐permeable contrast agent for brain tumor detection by MRI , 2010, Magnetic resonance in medicine.

[149]  Ke Tao,et al.  Facile Interfacial Coprecipitation To Fabricate Hydrophilic Amine-Capped Magnetite Nanoparticles , 2006 .

[150]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[151]  Mathias Hoehn,et al.  Cell tracking using magnetic resonance imaging , 2007, The Journal of physiology.

[152]  D. Holdsworth,et al.  Micro-CT in small animal and specimen imaging , 2002 .

[153]  D. Letourneur,et al.  Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque , 2007, Magnetic Resonance Materials in Physics, Biology and Medicine.

[154]  A. Phelan,et al.  Intercellular delivery of functional p53 by the herpesvirus protein VP22 , 1998, Nature Biotechnology.

[155]  Jeff W M Bulte,et al.  Monitoring cell therapy using iron oxide MR contrast agents. , 2004, Current pharmaceutical biotechnology.

[156]  K. Jun,et al.  Nonaqueous synthesis and characterization of capped α-Fe2O3 nanoparticles from iron(III) hydroxy-oleate precursor , 2008 .

[157]  Valérie Cabuil,et al.  Fluorescence-modified superparamagnetic nanoparticles: intracellular uptake and use in cellular imaging. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[158]  Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice. , 2010, Radiology.

[159]  A. Kassner,et al.  Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model. , 2010, Contrast media & molecular imaging.

[160]  Takashi Ishikawa,et al.  VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice , 2002, Cancer Gene Therapy.

[161]  Nicolas Grenier,et al.  In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. , 2004, Radiology.

[162]  A. Sinusas Multimodality Cardiovascular Molecular Imaging: An Overview , 2010, Journal of Nuclear Medicine.

[163]  R. Choudhury,et al.  An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide☆ , 2010, Atherosclerosis.

[164]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[165]  S. Seltzer,et al.  Radiopaque liposomes: a promising new contrast material for computed tomography of the spleen. , 1981, Radiology.

[166]  R. Weissleder,et al.  Optical Imaging of Spontaneous Breast Tumors Using Protease Sensing ‘Smart’ Optical Probes , 2005, Investigative radiology.

[167]  R. Zarnegar,et al.  Bone metastases from differentiated thyroid carcinoma. , 2008, Endocrine-related cancer.

[168]  Morteza Mahmoudi,et al.  Effect of nanoparticles on the cell life cycle. , 2011, Chemical reviews.

[169]  P. Alivisatos The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[170]  J. Leor,et al.  Iron-Oxide Labeling and Outcome of Transplanted Mesenchymal Stem Cells in the Infarcted Myocardium , 2007, Circulation.

[171]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[172]  H. Wester,et al.  Molecular imaging targeting peptide receptors. , 2009, Methods.

[173]  Abbas S. Milani,et al.  Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review , 2010 .

[174]  Karthikeyan Subramani,et al.  Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.

[175]  R. Weissleder,et al.  Noninvasive imaging of apoptosis in cardiovascular disease , 2008, Heart Failure Reviews.

[176]  R. Müller,et al.  A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour , 2002, Journal of drug targeting.

[177]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[178]  M. Sahraian,et al.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. , 2011, ACS chemical neuroscience.

[179]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[180]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[181]  A. Lowe,et al.  The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry , 2007, NMR in biomedicine.

[182]  S. Laurent,et al.  Iron oxide based MR contrast agents: from chemistry to cell labeling. , 2009, Current medicinal chemistry.

[183]  E. Melamed,et al.  Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases , 2009, Expert opinion on biological therapy.

[184]  Ralph Weissleder,et al.  Magnetic relaxation switch immunosensors detect enantiomeric impurities. , 2004, Angewandte Chemie.

[185]  J. Ripoll,et al.  Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[186]  A. De Gaetano,et al.  A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy , 2008, Oncology.

[187]  M. Mahmoudi,et al.  Cytotoxicity of Uncoated and Polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles , 2009 .

[188]  P. Renshaw,et al.  Immunospecific NMR contrast agents. , 1986, Magnetic resonance imaging.

[189]  T. Park,et al.  Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI. , 2010, Magnetic resonance imaging.

[190]  Dianna D Cody,et al.  In vivo respiratory-gated micro-CT imaging in small-animal oncology models. , 2004, Molecular imaging.

[191]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[192]  R. Weissleder,et al.  Fluorescence molecular imaging of small animal tumor models. , 2004, Current molecular medicine.

[193]  T. Nagai,et al.  Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. , 2008, Journal of biomedical materials research. Part A.

[194]  P. Renshaw,et al.  Relaxation and imaging of lithium in vivo. , 1986, Magnetic resonance imaging.

[195]  S. Caruthers,et al.  High Sensitivity: High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model , 2009, Investigative radiology.

[196]  T. Leiner,et al.  Highly accelerated first‐pass contrast‐enhanced magnetic resonance angiography of the peripheral vasculature: Comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents , 2009, Journal of magnetic resonance imaging : JMRI.

[197]  Werner Jaschke,et al.  Molecular imaging with nanoparticles: giant roles for dwarf actors , 2008, Histochemistry and Cell Biology.

[198]  Weibo Cai,et al.  Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.

[199]  Ralph Weissleder,et al.  A fluorescent nanosensor for apoptotic cells. , 2006, Nano letters.

[200]  Jinwoo Cheon,et al.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. , 2008, Angewandte Chemie.

[201]  Q. Pankhurst,et al.  Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. , 2009, Cancer research.

[202]  D. Butterfield,et al.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.

[203]  C.-C. Jay Kuo,et al.  Geometric feature-based multimodal image registration of contrast-enhanced cardiac CT with gated myocardial perfusion SPECT. , 2009, Medical physics.

[204]  L. Williams,et al.  Localisation of experimental staphylococcal abscesses by 99MTC-technetium-labelled liposomes. , 1981, Journal of medical microbiology.

[205]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.

[206]  K. Watkin,et al.  Multi-modal contrast agents: a first step. , 2002, Academic radiology.

[207]  M. Mahmoudi,et al.  Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications , 2010 .

[208]  P. Lauterbur,et al.  Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance , 1973, Nature.

[209]  Xiaogang Peng,et al.  Size- and Shape-Controlled Magnetic (Cr, Mn, Fe, Co, Ni) Oxide Nanocrystals via a Simple and General Approach , 2004 .

[210]  B. Hamm,et al.  Protease-specific nanosensors for magnetic resonance imaging. , 2008, Bioconjugate chemistry.

[211]  David Parker,et al.  Luminescent lanthanide sensors for pH, pO2 and selected anions , 2000 .

[212]  Bernd Hamm,et al.  Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging: Preclinical In Vivo Characterization , 2002, Investigative radiology.

[213]  S E Seltzer,et al.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. , 1995, Radiology.

[214]  Sophie Gaillard,et al.  Safety and Tolerability of Ultrasmall Superparamagnetic Iron Oxide Contrast Agent: Comprehensive Analysis of a Clinical Development Program , 2009, Investigative radiology.

[215]  P. Seeburg,et al.  Using reporter genes to label selected neuronal populations in transgenic mice for gene promoter, anatomical, and physiological studies , 2001, Progress in Neurobiology.

[216]  Z. John Zhang,et al.  Reverse Micelle Synthesis and Characterization of Superparamagnetic MnFe2O4 Spinel Ferrite Nanocrystallites , 2000 .

[217]  Jos Jonkers,et al.  Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. , 2002, Cancer research.

[218]  Shiyuan Liu,et al.  Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Noninvasively Characterizing the Different Αvβ3 Expression Patterns in Lung Cancers with Rgd-uspio Using a Clinical 3.0t Mr Scanner , 2022 .

[219]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[220]  T. Bach‐Gansmo Ferrimagnetic susceptibility contrast agents. , 1993, Acta radiologica. Supplementum.

[221]  S S Gambhir,et al.  Use of positron emission tomography in animal research. , 2001, ILAR journal.

[222]  T. Ihalainen,et al.  Magnetic resonance imaging of viral particle biodistribution in vivo , 2006, Gene Therapy.

[223]  P. Low,et al.  Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. , 1994, The Journal of biological chemistry.

[224]  U. Haberkorn PET and SPECT. , 2008, Handbook of experimental pharmacology.

[225]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[226]  Timo Ropinski,et al.  Multimodal Vessel Visualization of Mouse Aorta PET/CT Scans , 2009, IEEE Transactions on Visualization and Computer Graphics.

[227]  Karl-Hans Englmeier,et al.  Multimodal virtual bronchoscopy using PET/CT images , 2008, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.

[228]  C. Kremser,et al.  Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[229]  Florea Lupu,et al.  Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering. , 2010, Tissue engineering. Part A.

[230]  Zahi A Fayad,et al.  Modified natural nanoparticles as contrast agents for medical imaging. , 2010, Advanced drug delivery reviews.

[231]  Ralph Weissleder,et al.  A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. , 2003, Cancer research.

[232]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[233]  Arion F. Chatziioannou,et al.  Molecular imaging of small animals with dedicated PET tomographs , 2001, European Journal of Nuclear Medicine and Molecular Imaging.

[234]  Sophie Laurent,et al.  Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. , 2006, Contrast media & molecular imaging.

[235]  T. Yamano,et al.  Detection of peritoneal micrometastases of gastric carcinoma with green fluorescent protein and carcinoembryonic antigen promoter. , 2001, Cancer research.

[236]  Thomas J. Meade,et al.  Multimodal MRI contrast agents , 2007, JBIC Journal of Biological Inorganic Chemistry.

[237]  M S Rosenthal,et al.  Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[238]  P. Mansfield Multi-planar image formation using NMR spin echoes , 1977 .

[239]  Y. Yamabe,et al.  Tumor staging of advanced esophageal cancer: combination of double-contrast esophagography and contrast-enhanced CT. , 2008, AJR. American journal of roentgenology.

[240]  M. V. van Zandvoort,et al.  Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. , 2008, Cancer research.

[241]  Xiang Li,et al.  Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. , 2010, International journal of pharmaceutics.

[242]  Mingyuan Gao,et al.  One-Pot Reaction to Synthesize Water-Soluble Magnetite Nanocrystals , 2004 .

[243]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[244]  A J Reader,et al.  Developments in whole-body molecular imaging of live subjects. , 2001, Trends in pharmacological sciences.

[245]  M. Rohany,et al.  Case Study of Tc-99m HMPAO Brain SPECT Imaging in a Patient With Hepatic Encephalopathy and Carotid Artery Stenosis , 2010, Clinical nuclear medicine.

[246]  D. Farkas,et al.  Optical Imaging of PKH‐Labeled Hematopoietic Cells in Recipient Bone Marrow In Vivo , 2002, Stem cells.

[247]  T. Dresselaers,et al.  Cell labeling and tracking for experimental models using magnetic resonance imaging. , 2009, Methods.

[248]  William D Rooney,et al.  Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[249]  M. Mahmoudi,et al.  Preparation and biological evaluation of radiolabeled-folate embedded superparamagnetic nanoparticles in wild-type rats , 2011 .

[250]  A. Fischman,et al.  Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.

[251]  Klaas Nicolay,et al.  Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging , 2006, NMR in biomedicine.

[252]  R. Weissleder,et al.  Monofunctional near-infrared fluorochromes for imaging applications. , 2005, Bioconjugate chemistry.

[253]  Meng Yang,et al.  Optically imageable metastatic model of human breast cancer , 2004, Clinical & Experimental Metastasis.

[254]  M. Mahmoudi,et al.  Preparation and biological evaluation of [67Ga]-labeled-superparamagnetic nanoparticles in normal rats , 2009 .

[255]  René M. Botnar,et al.  Molecular Imaging With Targeted Contrast Agents , 2009, Topics in magnetic resonance imaging : TMRI.

[256]  R. Weissleder A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[257]  N de Jong,et al.  Usefulness of power Doppler contrast echocardiography to identify reperfusion after acute myocardial infarction. , 2001, The American journal of cardiology.

[258]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[259]  H. Hofmann,et al.  Superparamagnetic Iron Oxide Nanoparticles (SPIONs): From Synthesis to In Vivo Studies—A Summary of the Synthesis, Characterization, In Vitro, and In Vivo Investigations of SPIONs With Particular Focus on Surface and Colloidal Properties , 2007, IEEE Transactions on NanoBioscience.

[260]  P F Renshaw,et al.  Ferromagnetic contrast agents: A new approach , 1986, Magnetic resonance in medicine.

[261]  F. Stuart Foster,et al.  In vivo ultrasound biomicroscopy in developmental biology , 2002 .

[262]  Keren Ziv,et al.  MRI detection of transcriptional regulation of gene expression in transgenic mice , 2007, Nature Medicine.

[263]  M. Umetsu,et al.  Hydrothermal synthesis of surface-modified iron oxide nanoparticles , 2007 .

[264]  J. Kastrup,et al.  Mesenchymal stromal cells for cardiovascular repair: current status and future challenges. , 2009, Future cardiology.

[265]  M. Port,et al.  Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography. , 2000, Investigative radiology.

[266]  R. Ivkov,et al.  NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. , 2008, Bioconjugate chemistry.

[267]  P. Lauterbur,et al.  Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen , 1986, Magnetic resonance in medicine.

[268]  Jan Grimm,et al.  An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles , 2006, Nature materials.

[269]  Tzu-Chen Yen,et al.  In situ preparation of high relaxivity iron oxide nanoparticles by coating with chitosan: A potential MRI contrast agent useful for cell tracking , 2010 .

[270]  C. Hawker,et al.  The Advantages of Nanoparticles for PET , 2009, Journal of Nuclear Medicine.

[271]  E. Syková,et al.  Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. , 2009, Bioconjugate chemistry.

[272]  Antony K. Chen,et al.  Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.

[273]  W. Scheithauer,et al.  In vitro and in vivo studies of three radiolabelled somatostatin analogues:123I-Octreotide (OCT),123I-Tyr-3-OCT and111In-TIRA-d-Phe-1-OCT , 1996, European Journal of Nuclear Medicine.

[274]  You Han Bae,et al.  Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[275]  T. Vincent,et al.  An evolutionary model for initiation, promotion, and progression in carcinogenesis. , 2008, International journal of oncology.

[276]  Mingyuan Gao,et al.  Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications , 2009 .

[277]  Ming Zhao,et al.  Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.

[278]  G. Elliott,et al.  Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.

[279]  P. Hermann,et al.  Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. , 2008, Dalton transactions.

[280]  Akiyoshi Wada,et al.  Dextran-magnetite: A new relaxation reagent and its application to T2 measurements in gel systems , 1978 .

[281]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[282]  O. Döhr,et al.  Preclinical Safety Evaluation of Gd-EOB-DTPA (Primovist) , 2007, Investigative radiology.

[283]  Jae-pyoung Ahn,et al.  Sol–Gel Mediated Synthesis of Fe2O3 Nanorods , 2003 .

[284]  Lehui Lu,et al.  Fluorescent magnetic nanoprobes: design and application for cell imaging. , 2010, Journal of colloid and interface science.

[285]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[286]  K. Strijckmans The isochronous cyclotron: principles and recent developments. , 2001, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[287]  B E Bouma,et al.  Images in cardiovascular medicine. Catheter-based optical imaging of a human coronary artery. , 1996, Circulation.

[288]  J. Lippincott-Schwartz,et al.  Studying protein dynamics in living cells , 2001, Nature Reviews Molecular Cell Biology.

[289]  G. Liu,et al.  Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI. , 2008, Journal of biomedical materials research. Part A.